BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SEPT6, RP5-876A24_2, 23157, ENSG00000125354, Q14141, SEP2, MGC16619, KIAA0128, MGC20339 AND Treatment
43088 results:

  • 1. Beyond Chemoimmunotherapy in Advanced Non-Small Cell lung cancer: New Frontiers, New Challenges.
    Mountzios G; Naidoo J; Wang C; Creelan BC; Trotier DC; Campbell TC; Peters S
    Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432526. PubMed ID: 38781566
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [The use of medical imaging as a therapeutic patient education tool in radiotherapy : a feasibility study].
    Kirkove D; Ben Mustapha S; Jodogne S; Pétré B
    Rev Med Liege; 2024 May; 79(S1):100-106. PubMed ID: 38778656
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses.
    Martinez DR; Moreira FR; Catanzaro NJ; Diefenbacher MV; Zweigart MR; Gully KL; De la Cruz G; Brown AJ; Adams LE; Yount B; Baric TJ; Mallory ML; Conrad H; May SR; Dong S; Scobey DT; Nguyen C; Montgomery SA; Perry JK; Babusis D; Barrett KT; Nguyen AH; Nguyen AQ; Kalla R; Bannister R; Feng JY; Cihlar T; Baric RS; Mackman RL; Bilello JP; Schäfer A; Sheahan TP
    Sci Transl Med; 2024 May; 16(748):eadj4504. PubMed ID: 38776389
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
    Luo W; Chang G; Lin D; Xie H; Sun H; Li Z; Mo S; Wang R; Wang Y; Zheng Z
    PLoS One; 2024; 19(5):e0303186. PubMed ID: 38776295
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis.
    Meder L; Orschel CI; Otto CJ; Koker M; Brägelmann J; Ercanoglu MS; Dähling S; Compes A; Selenz C; Nill M; Dietlein F; Florin A; Eich ML; Borchmann S; Odenthal M; Blazquez R; Hilberg F; Klein F; Hallek M; Büttner R; Reinhardt HC; Ullrich RT
    JCI Insight; 2024 May; 9(10):. PubMed ID: 38775153
    [TBL] [Abstract] [Full Text] [Related]  

  • 6.
    McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
    Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
    [No Abstract]    [Full Text] [Related]  

  • 7. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
    Ma H; Wu T; Zhang Q; Ding Q
    BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Interventions for smoking cessation in hospitalised patients.
    Streck JM; Rigotti NA; Livingstone-Banks J; Tindle HA; Clair C; Munafò MR; Sterling-Maisel C; Hartmann-Boyce J
    Cochrane Database Syst Rev; 2024 May; 5(5):CD001837. PubMed ID: 38770804
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical Multi-features Analysis of Cystic lung Adenocarcinoma 
and Construction of Invasive Risk Prediction Model].
    Wang Q; Fu C; Wang K; Ren Q; Chen A; Xu X; Chen L; Zhu Q
    Zhongguo Fei Ai Za Zhi; 2024 Apr; 27(4):266-275. PubMed ID: 38769829
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival Predictive Nomograms for Non-Surgical Brain Metastases Patients From Non-Small Cell lung cancer Receiving Radiotherapy: A Population-Based Study.
    Li P; Luo J; Zheng Z; Meng L; Zhang A; Cao W; Gong X
    Cancer Control; 2024; 31():10732748241255212. PubMed ID: 38769789
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Fatal COVID-19 pulmonary disease involves ferroptosis.
    Qiu B; Zandkarimi F; Saqi A; Castagna C; Tan H; Sekulic M; Miorin L; Hibshoosh H; Toyokuni S; Uchida K; Stockwell BR
    Nat Commun; 2024 May; 15(1):3816. PubMed ID: 38769293
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Strategies to address recruitment to a randomised trial of surgical and non-surgical treatment for cancer: results from a complex recruitment intervention within the Mesothelioma and Radical Surgery 2 (MARS 2) study.
    Mills N; Farrar N; Warnes B; Ashton KE; Harris R; Rogers CA; Lim E; Elliott D
    BMJ Open; 2024 May; 14(5):e079108. PubMed ID: 38760029
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Potential mechanism of Chai Gui Zexie Decoction for NSCLC treatment assessed using network pharmacology, bioinformatics, and molecular docking: An observational study.
    Lin M; Zhao A; Chen B
    Medicine (Baltimore); 2024 May; 103(20):e38204. PubMed ID: 38758858
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
    Yin X; Liu X; Ren F; Meng X
    Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
    Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell lung cancer.
    Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
    JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Second Chance for Cure: Stereotactic Ablative Radiotherapy in Oligometastatic Disease.
    Salim N; Tumanova K; Popodko A; Libson E
    JCO Glob Oncol; 2024 May; 10():e2300275. PubMed ID: 38754052
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-world osimertinib pretreatment experience in patients with epidermal growth factor receptor T790M mutation-positive locally advanced or metastatic non-small cell lung cancer.
    Chang GC; Shih JY; Yu CJ; Chao HS; Yang CT; Lin CC; Hung JY; Hsiao SY; Wang CC; Chian CF; Hsia TC; Chen YM
    PLoS One; 2024; 19(5):e0303046. PubMed ID: 38753697
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2155.